Rtw Investments, LP Taysha Gene Therapies, Inc. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 14,946,420 shares of TSHA stock, worth $27.4 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
14,946,420
Previous 18,800,299
20.5%
Holding current value
$27.4 Million
Previous $42.1 Million
28.66%
% of portfolio
0.48%
Previous 0.7%
Shares
4 transactions
Others Institutions Holding TSHA
# of Institutions
118Shares Held
136MCall Options Held
25.9KPut Options Held
24K-
Avoro Capital Advisors LLC New York, NY18.7MShares$34.1 Million0.56% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$21.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$19.9 Million0.3% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$16.5 Million1.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.27MShares$15.1 Million0.0% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $88.5M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...